Vectron Biosolutions

About:

Vectron Biosolutions develops and markets vector technologies to biotechnology and life science industries.

Website: https://www.vectronbiosolutions.com

Top Investors: Dynamk Capital

Description:

Vectron Biosolutions is develops and markets vector technologies to biotechnology and life science industries. The company offers bacterial cloning vectors; expression vectors engineered for recombinant protein production in bacteria; customize vectors for specific applications; and recombinant proteins. It also provides protein production, vector design, and molecular engineering services to help its clients in life science research activities.

Total Funding Amount:

$2.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Trondheim, Sor-Trondelag, Norway

Founded Date:

2008-05-19

Founders:

Trond Erik Vee Aune

Number of Employees:

11-50

Last Funding Date:

2021-06-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai